Skip to main navigation Skip to search Skip to main content

Proceedings of the signature series symposium “cellular therapies for orthopaedics and musculoskeletal disease proven and unproven therapies—promise, facts and fantasy,” international society for cellular therapies, montreal, canada, may 2, 2018

  • NICOLAS S. Piuzzi
  • , M. DOMINICI
  • , M. A.R.C. LONG
  • , C. PASCUAL-GARRIDO
  • , S. RODEO
  • , J. HUARD
  • , JÉROME GUICHEUX
  • , R. MCFARLAND
  • , LAURIE R. GOODRICH
  • , STÉPHANE MADDENS
  • , PAMELA G. ROBEY
  • , THOMAS W. BAUER
  • , J. O.H.N. BARRETT
  • , F. BARRY
  • , D. KARLI
  • , CONSTANCE R. CHU
  • , DANIEL J. WEISS
  • , I. V.A.N. MARTIN
  • , C. JORGENSEN
  • , GEORGE F. MUSCHLER*
  • *Corresponding author for this work
  • Cleveland Clinic Foundation
  • Hospital Italiano de Buenos Aires
  • University of Modena and Reggio Emilia
  • MTF Biologics
  • Washington University St. Louis
  • Hospital for Special Surgery - New York
  • University of Texas Health Science Center at Houston
  • Steadman Philippon Research Institute
  • Inserm
  • Advanced Regenerative Manufacturing Institute
  • Colorado State University
  • Vetbiobank
  • National Institutes of Health
  • National University of Ireland
  • Greyledge Technologies, LLC
  • Stanford University
  • Veterans Affairs Medical Center
  • University of Vermont
  • University of Basel
  • CHU Montpellier

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Abstract

The Signature Series Symposium “Cellular Therapies for Orthopaedics and Musculoskeletal Disease Proven and Unproven Therapies—Promise, Facts and Fantasy” was held as a pre-meeting of the 26th International Society for Cellular Therapy (ISCT) annual congress in Montreal, Canada, May 2, 2018. This was the first ISCT program that was entirely dedicated to the advancement of cell-based therapies for musculoskeletal diseases. Cellular therapies in musculoskeletal medicine are a source of great promise and opportunity. They are also the source of public controversy, confusion and misinformation. Patients, clinicians, scientists, industry and government share a commitment to clear communication and responsible development of the field. Therefore, this symposium convened thought leaders from around the world in a forum designed to catalyze communication and collaboration to bring the greatest possible innovation and value to patients with musculoskeletal conditions.

Original languageEnglish
Pages (from-to)1381-1400
Number of pages20
JournalCytotherapy
Volume20
Issue number11
DOIs
StatePublished - Nov 2018
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Proceedings of the signature series symposium “cellular therapies for orthopaedics and musculoskeletal disease proven and unproven therapies—promise, facts and fantasy,” international society for cellular therapies, montreal, canada, may 2, 2018'. Together they form a unique fingerprint.

Cite this